Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,744Revenue $M872Net Margin (%)24.8Z-Score3.7
Enterprise Value $M10,672EPS $3.5Operating Margin %39.0F-Score5
P/E(ttm))130Cash Flow Per Share $3.6Pre-tax Margin (%)35.3Higher ROA y-yN
Price/Book7.410-y EBITDA Growth Rate %0Quick Ratio2.6Cash flow > EarningsY
Price/Sales9.85-y EBITDA Growth Rate %68.1Current Ratio2.8Lower Leverage y-yN
Price/Cash Flow14.2y-y EBITDA Growth Rate %-11.9ROA % (ttm)9.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)16.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M59.4ROI % (ttm)19.6Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JAZZGeorge Soros 2014-06-30 Sold Out $124.63 - $154.82
($138.55)
$ 162.7117%Sold Out0
JAZZSteve Mandel 2014-06-30 Reduce-0.15%$124.63 - $154.82
($138.55)
$ 162.7117%Reduce -10.98%2,087,127
JAZZJoel Greenblatt 2014-06-30 Sold Out -0.02%$124.63 - $154.82
($138.55)
$ 162.7117%Sold Out0
JAZZSteve Mandel 2014-03-31 Buy 1.4%$125.51 - $174.98
($149.95)
$ 162.718%New holding, 2344486 sh.2,344,486
JAZZJoel Greenblatt 2014-03-31 Buy 0.02%$125.51 - $174.98
($149.95)
$ 162.718%New holding, 7367 sh.7,367
JAZZGeorge Soros 2014-03-31 Buy $125.51 - $174.98
($149.95)
$ 162.718%New holding, 3600 sh.3,600
JAZZJohn Paulson 2013-12-31 Sold Out -0.57%$82.62 - $126.79
($103.31)
$ 162.7158%Sold Out0
JAZZJohn Paulson 2012-09-30 Buy 0.47%$44.4 - $58.5
($48.28)
$ 162.71237%New holding, 1000000 sh.1,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
JAZZ Steve Mandel 2014-06-302,087,1273.511.2-10.98%
JAZZ George Soros 2014-06-30000Sold Out
JAZZ Joel Greenblatt 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hooper Suzanne SawochkaEVP and General Counsel 2014-08-15Sell667$1508.74view
BERNS PAUL LDirector 2014-08-12Sell1,087$133.1522.5view
ENRIGHT PATRICK GDirector 2014-08-12Sell1,087$133.1522.5view
Sohn Catherine A.Director 2014-08-12Sell1,731$133.1522.5view
Winningham Rick EDirector 2014-08-12Sell1,087$133.1522.5view
Hooper Suzanne SawochkaEVP and General Counsel 2014-08-12Sell1,185$133.1522.5view
COZADD BRUCE CChairman and CEO 2014-08-12Sell5,000$133.1522.5view
Tobias Jeffrey KEVP, Research & Dev and CMO 2014-08-11Sell4,933$135.4220.45view
COZADD BRUCE CChairman and CEO 2014-07-08Sell5,000$1555.23view
Keegan FintanEVP, Technical Operations 2014-07-08Sell1,991$1555.23view

Press Releases about JAZZ :

    Quarterly/Annual Reports about JAZZ:

    News about JAZZ:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 
    Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
    Weekly CFO Sells Highlight: Jazz Pharmaceuticals PLC, Carnival PLC, Juniper Networks Inc., Home Depo Mar 10 2014 
    comment on JAZZ Mar 21 2013 
    optimized portfolio Jul 26 2011 
    Jazz Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
    Jazz Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
    Jazz Pharmaceuticals Inc. (JAZZ) CFO Kathryn E Falberg buys 50,000 Shares Sep 01 2010 
    Jazz Pharmaceuticals Inc. (JAZZ) CEO Bruce C Cozadd buys 10,000 Shares Sep 01 2010 


    More From Other Websites
    Gilead, Jazz Among 4 Top Big Cap Medicals To Watch Aug 27 2014
    Jazz Pharmaceuticals (JAZZ) Shares March Higher, Can It Continue? Aug 21 2014
    Allergan Talks to Buy Salix in Defense Move Said to Be Dormant Aug 20 2014
    Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up Aug 20 2014
    [video] Faber Report: WSJ says Allergan approaches Salix Aug 20 2014
    Indexes Rally On Strong Housing Data, Retail Reports Aug 19 2014
    Stocks Add To Gains; Salix Surges On Potential Bid Aug 19 2014
    JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition' Aug 19 2014
    Why Jazz Pharmaceuticals (JAZZ) Stock Is Gaining Today Aug 19 2014
    Will This Coverage Initiation Help Jazz Pharmaceuticals (JAZZ) Stock Today? Aug 19 2014
    Jazz, Celgene Lead Top 4 Drugmaker Profit Margins Aug 18 2014
    Stocks Backslide Into Losses; Jazz Pharma, Kinder Morgan Rise Aug 15 2014
    Jazz Pharmaceuticals (JAZZ) Is Today's Momo Momentum Stock Aug 15 2014
    Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% Aug 14 2014
    [video] Airline Stocks Soar, Boosting U.S. Stock Market Rally Aug 13 2014
    JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Aug 13 2014
    Watch Out: Barbarians At The Gate For Jazz Pharmaceuticals (JAZZ) Aug 13 2014
    Nasdaq Leads Indexes As Solar, Biotechs Outperform Aug 13 2014
    Jazz Pharmaceuticals PLC Stock Upgraded (JAZZ) Aug 13 2014
    JAZZ PHARMACEUTICALS PLC Financials Aug 12 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK